Abstract
The U.S. Market for Bone Morphogenic Proteins (BMPs) in Orthopaedics report is presented as a Microsoft Powerpoint presentation and contains more than 50 figures and tables that are ideal for marketing purposes.
The report is designed to provide a detailed overview of current developments in bone morphogenic proteins for use in spinal fusion applications. The goals of the report are to identify market drivers, restraints and technological and business issues that will impact the BMP market. The aims are to provide an improved understanding of the market and technology, so that decision-makers are able to evaluate and consider opportunities within the market.
The report identifies key BMP products, including their individual histories and applications. Revenue forecasts, market shares and pricing information are reported.
The information presented in this report has been collated from interviews with manufacturers, distributors, universities, orthopaedic surgeons, company literature, conference proceedings, and related company information.
Table of Contents
Chapter 1 Introduction
- Bone Grafting
- Biological Activity of Bone Grafts
- Current Bone Graft Technologies and Applications
- Autografts
- Advantages of Autografts
- Limitation of Autografts
- Machined Allografts
- Advantages and Limitations of Machined Allografts
- Synthetic Bone Graft Substitutes
- Advantages and Limitations of Synthetic Bone Graft Substitutes
- Demineralised Bone Matrix
- Advantages and Disadvantages of Demineralised Bone Matrices
- Bone Morphogenic Proteins
- Advantages and Limitations of Bone Morphogenic Proteins
- Comparative Properties of Autografts and Allografts
- Comparative Properties of Synthetic and Cell-Based Bone Graft Substitutes
Chapter 2 Orthopaedic Procedures and Bone Graft Utilisation
- Bone Graft Utilisation in Orthopaedic Applications (U.S., 2004)
- Total Number of Spinal Fusion Procedures in U.S., 2004
- Total Number of Spinal Fusion Procedures by Selected Geographic Regions in the U.S., 2004
- Total Number of Spinal Fusion Procedures by Anatomy, U.S., 2004
Chapter 5 Bone Morphogenic Proteins (BMP) Market
- Market Drivers and Restraints
- Market Opportunities
- End-User Trends
- Industry Challenges
- Market Challenges
- BMP Products
- rhBMP-2/ACS (marketed as InFUSE Graft in the U.S., and as InductOS in Europe)
- History of rhBMP-2/ACS
- Product Description
- Development of rhBMP/ACS
- Preclinical Studies
- Clinical Studies
- Indications and Contradictions
- Development of InductOS in Europe
- OP-1
- Development of OP-1
- Product Description
- Preclinical Studies
- Clinical Studies
- FDA Indications and Contradictions
- MP52
- Product Description
- History of Development
- Preclinical and Clinical Studies
- FDA Status
- Pricing Analysis
- Pricing Forecasts for BMPs
- U.S. Market Size for BMPs
- Revenue Analysis
- U.S. Unit Shipments of BMPs
- Analysis of Unit Shipment of BMPs in the U.S.
- Surgeons Prospective
